Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wounds and Injuries | 16 | 2022 | 183 | 3.280 |
Why?
|
| Air Ambulances | 6 | 2020 | 20 | 2.650 |
Why?
|
| Trauma Centers | 12 | 2022 | 118 | 1.620 |
Why?
|
| Brain Injuries, Traumatic | 2 | 2022 | 36 | 1.260 |
Why?
|
| Emergency Medical Services | 6 | 2022 | 81 | 1.210 |
Why?
|
| Ambulances | 3 | 2020 | 12 | 1.140 |
Why?
|
| Surgeons | 3 | 2023 | 50 | 1.130 |
Why?
|
| Injury Severity Score | 10 | 2022 | 121 | 1.090 |
Why?
|
| Retrospective Studies | 24 | 2025 | 2546 | 0.930 |
Why?
|
| Complement C1 Inhibitor Protein | 1 | 2023 | 3 | 0.860 |
Why?
|
| Veterans | 2 | 2022 | 69 | 0.850 |
Why?
|
| Elasticity | 1 | 2023 | 52 | 0.810 |
Why?
|
| Humans | 50 | 2025 | 28094 | 0.810 |
Why?
|
| Platelet Function Tests | 1 | 2022 | 24 | 0.800 |
Why?
|
| Coronary Artery Bypass | 1 | 2022 | 68 | 0.770 |
Why?
|
| Brain Ischemia | 1 | 2023 | 85 | 0.770 |
Why?
|
| Venous Thromboembolism | 1 | 2023 | 133 | 0.740 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2022 | 69 | 0.730 |
Why?
|
| Afghan Campaign 2001- | 2 | 2022 | 11 | 0.710 |
Why?
|
| Iraq War, 2003-2011 | 2 | 2022 | 11 | 0.710 |
Why?
|
| Headache | 2 | 2022 | 34 | 0.710 |
Why?
|
| Blood Platelets | 1 | 2023 | 206 | 0.700 |
Why?
|
| Diabetes Mellitus | 1 | 2023 | 215 | 0.700 |
Why?
|
| Transportation of Patients | 2 | 2019 | 29 | 0.660 |
Why?
|
| Stroke | 1 | 2023 | 252 | 0.650 |
Why?
|
| Registries | 8 | 2019 | 387 | 0.620 |
Why?
|
| Hospital Mortality | 4 | 2020 | 147 | 0.600 |
Why?
|
| Patient Discharge | 4 | 2022 | 104 | 0.590 |
Why?
|
| Rural Health Services | 1 | 2018 | 24 | 0.580 |
Why?
|
| General Surgery | 3 | 2021 | 55 | 0.500 |
Why?
|
| Adolescent | 11 | 2025 | 3121 | 0.460 |
Why?
|
| Rural Population | 2 | 2016 | 108 | 0.450 |
Why?
|
| Postoperative Complications | 4 | 2024 | 611 | 0.440 |
Why?
|
| Triage | 4 | 2022 | 33 | 0.430 |
Why?
|
| Blood Transfusion | 3 | 2023 | 77 | 0.430 |
Why?
|
| Emergency Service, Hospital | 6 | 2024 | 120 | 0.420 |
Why?
|
| Acute Kidney Injury | 2 | 2024 | 74 | 0.420 |
Why?
|
| Cholelithiasis | 2 | 2024 | 10 | 0.420 |
Why?
|
| Wounds, Nonpenetrating | 2 | 2025 | 52 | 0.410 |
Why?
|
| Propensity Score | 2 | 2019 | 54 | 0.410 |
Why?
|
| Thrombelastography | 2 | 2023 | 47 | 0.400 |
Why?
|
| Female | 21 | 2025 | 15153 | 0.380 |
Why?
|
| Case-Control Studies | 4 | 2018 | 722 | 0.380 |
Why?
|
| Male | 19 | 2025 | 13489 | 0.370 |
Why?
|
| Ambulatory Care Facilities | 2 | 2024 | 54 | 0.360 |
Why?
|
| Automobiles | 1 | 2011 | 2 | 0.360 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 28 | 0.350 |
Why?
|
| Abbreviated Injury Scale | 1 | 2010 | 4 | 0.350 |
Why?
|
| Adult | 14 | 2024 | 7739 | 0.340 |
Why?
|
| Risk Factors | 8 | 2024 | 2081 | 0.320 |
Why?
|
| Telemedicine | 2 | 2022 | 174 | 0.310 |
Why?
|
| Internship and Residency | 2 | 2021 | 239 | 0.290 |
Why?
|
| Child | 8 | 2025 | 2242 | 0.290 |
Why?
|
| Oklahoma | 5 | 2018 | 1007 | 0.290 |
Why?
|
| Patient Transfer | 4 | 2022 | 43 | 0.270 |
Why?
|
| Cholecystectomy | 2 | 2024 | 15 | 0.270 |
Why?
|
| Middle Aged | 12 | 2024 | 7137 | 0.260 |
Why?
|
| Obesity | 2 | 2023 | 669 | 0.250 |
Why?
|
| Blood Coagulation | 2 | 2023 | 118 | 0.240 |
Why?
|
| Thoracic Injuries | 1 | 2025 | 10 | 0.240 |
Why?
|
| Bronchoscopy | 2 | 2024 | 34 | 0.240 |
Why?
|
| Vascular System Injuries | 1 | 2025 | 19 | 0.240 |
Why?
|
| Body Size | 1 | 2025 | 37 | 0.240 |
Why?
|
| Glasgow Coma Scale | 2 | 2018 | 18 | 0.240 |
Why?
|
| Aorta, Thoracic | 1 | 2025 | 55 | 0.230 |
Why?
|
| Endovascular Procedures | 1 | 2025 | 70 | 0.230 |
Why?
|
| Thoracic Surgery | 1 | 2024 | 14 | 0.220 |
Why?
|
| Erythrocyte Transfusion | 1 | 2024 | 15 | 0.220 |
Why?
|
| Postpartum Hemorrhage | 1 | 2024 | 10 | 0.220 |
Why?
|
| Spleen | 2 | 2021 | 112 | 0.220 |
Why?
|
| Surgical Procedures, Operative | 2 | 2024 | 50 | 0.210 |
Why?
|
| Robotic Surgical Procedures | 1 | 2024 | 45 | 0.210 |
Why?
|
| Sex Factors | 3 | 2021 | 466 | 0.210 |
Why?
|
| Lung Neoplasms | 2 | 2022 | 356 | 0.210 |
Why?
|
| Antifibrinolytic Agents | 1 | 2023 | 25 | 0.210 |
Why?
|
| Aged | 10 | 2024 | 5400 | 0.210 |
Why?
|
| Child, Preschool | 4 | 2020 | 1146 | 0.210 |
Why?
|
| Blood Coagulation Factors | 1 | 2023 | 31 | 0.210 |
Why?
|
| Medicine | 1 | 2023 | 22 | 0.200 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 26 | 0.200 |
Why?
|
| Logistic Models | 2 | 2016 | 407 | 0.200 |
Why?
|
| Needs Assessment | 2 | 2019 | 55 | 0.200 |
Why?
|
| Metastasectomy | 1 | 2022 | 6 | 0.200 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 82 | 0.200 |
Why?
|
| Afghanistan | 1 | 2022 | 3 | 0.200 |
Why?
|
| Iraq | 1 | 2022 | 4 | 0.200 |
Why?
|
| Surgical Wound Infection | 1 | 2023 | 105 | 0.200 |
Why?
|
| Dizziness | 1 | 2022 | 10 | 0.200 |
Why?
|
| Platelet Count | 1 | 2023 | 111 | 0.190 |
Why?
|
| Cholecystitis | 1 | 2022 | 3 | 0.190 |
Why?
|
| Tertiary Care Centers | 2 | 2021 | 27 | 0.190 |
Why?
|
| Quality Improvement | 1 | 2023 | 115 | 0.190 |
Why?
|
| Spine | 1 | 2022 | 61 | 0.190 |
Why?
|
| Thrombosis | 1 | 2023 | 149 | 0.190 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 90 | 0.190 |
Why?
|
| Consumer Advocacy | 1 | 2021 | 10 | 0.190 |
Why?
|
| Abdominal Injuries | 1 | 2021 | 29 | 0.190 |
Why?
|
| Social Justice | 1 | 2021 | 15 | 0.190 |
Why?
|
| Appendiceal Neoplasms | 1 | 2021 | 5 | 0.180 |
Why?
|
| Proportional Hazards Models | 3 | 2022 | 226 | 0.180 |
Why?
|
| Hemorrhage | 1 | 2023 | 265 | 0.180 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2023 | 173 | 0.180 |
Why?
|
| Cytoreduction Surgical Procedures | 1 | 2021 | 33 | 0.180 |
Why?
|
| Immunization, Secondary | 1 | 2020 | 10 | 0.180 |
Why?
|
| Aircraft | 1 | 2020 | 4 | 0.180 |
Why?
|
| Vaccination Coverage | 1 | 2020 | 13 | 0.180 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 138 | 0.180 |
Why?
|
| Splenectomy | 1 | 2020 | 44 | 0.170 |
Why?
|
| Postoperative Care | 1 | 2020 | 68 | 0.170 |
Why?
|
| Patient Compliance | 1 | 2020 | 75 | 0.170 |
Why?
|
| Hepatectomy | 1 | 2020 | 26 | 0.170 |
Why?
|
| Wounds, Gunshot | 1 | 2020 | 18 | 0.170 |
Why?
|
| United States | 2 | 2023 | 2146 | 0.170 |
Why?
|
| Thoracostomy | 1 | 2019 | 4 | 0.160 |
Why?
|
| Vena Cava Filters | 1 | 2019 | 11 | 0.160 |
Why?
|
| Chest Tubes | 1 | 2019 | 9 | 0.160 |
Why?
|
| Needles | 1 | 2019 | 26 | 0.160 |
Why?
|
| Device Removal | 1 | 2019 | 30 | 0.160 |
Why?
|
| Pneumothorax | 1 | 2019 | 15 | 0.160 |
Why?
|
| Emergency Treatment | 1 | 2019 | 26 | 0.160 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 971 | 0.160 |
Why?
|
| Traumatology | 1 | 2019 | 20 | 0.160 |
Why?
|
| Age Factors | 2 | 2018 | 734 | 0.150 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 961 | 0.150 |
Why?
|
| Pulmonary Embolism | 1 | 2019 | 126 | 0.150 |
Why?
|
| Liver Neoplasms | 1 | 2020 | 165 | 0.150 |
Why?
|
| Spouse Abuse | 1 | 1998 | 3 | 0.150 |
Why?
|
| Fibromyalgia | 1 | 1998 | 13 | 0.150 |
Why?
|
| Analgesics | 1 | 1998 | 38 | 0.140 |
Why?
|
| Survivors | 1 | 1998 | 40 | 0.140 |
Why?
|
| Anticoagulants | 1 | 2019 | 294 | 0.140 |
Why?
|
| Child Abuse | 1 | 1998 | 92 | 0.130 |
Why?
|
| Hospitals, Animal | 1 | 2016 | 1 | 0.130 |
Why?
|
| Multivariate Analysis | 2 | 2021 | 302 | 0.130 |
Why?
|
| Pain | 1 | 1998 | 258 | 0.120 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 474 | 0.120 |
Why?
|
| Young Adult | 5 | 2021 | 2732 | 0.120 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 414 | 0.120 |
Why?
|
| Infant, Newborn | 1 | 2018 | 885 | 0.110 |
Why?
|
| Prevalence | 1 | 2016 | 497 | 0.110 |
Why?
|
| Infant | 1 | 2018 | 1004 | 0.110 |
Why?
|
| Risk Assessment | 3 | 2024 | 612 | 0.110 |
Why?
|
| Electromagnetic Phenomena | 2 | 2024 | 15 | 0.100 |
Why?
|
| Clinical Competence | 3 | 2021 | 229 | 0.100 |
Why?
|
| Ultrasonography | 2 | 2024 | 241 | 0.100 |
Why?
|
| Thoracic Surgery, Video-Assisted | 1 | 2011 | 10 | 0.090 |
Why?
|
| Thoracotomy | 1 | 2011 | 16 | 0.090 |
Why?
|
| Quality Indicators, Health Care | 1 | 2011 | 49 | 0.090 |
Why?
|
| Geography | 1 | 2011 | 49 | 0.090 |
Why?
|
| Clinical Coding | 1 | 2010 | 7 | 0.090 |
Why?
|
| Observer Variation | 1 | 2010 | 43 | 0.090 |
Why?
|
| Wounds, Penetrating | 2 | 2020 | 25 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2025 | 2377 | 0.080 |
Why?
|
| Length of Stay | 2 | 2025 | 229 | 0.080 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2021 | 0.070 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 1013 | 0.070 |
Why?
|
| Algorithms | 1 | 2010 | 430 | 0.070 |
Why?
|
| Program Evaluation | 2 | 2020 | 167 | 0.060 |
Why?
|
| Aminocaproic Acid | 1 | 2023 | 6 | 0.050 |
Why?
|
| Delivery, Obstetric | 1 | 2024 | 39 | 0.050 |
Why?
|
| Factor Xa | 1 | 2023 | 14 | 0.050 |
Why?
|
| Thrombin | 1 | 2024 | 69 | 0.050 |
Why?
|
| Postpartum Period | 1 | 2024 | 72 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2023 | 16 | 0.050 |
Why?
|
| Blood Loss, Surgical | 1 | 2023 | 53 | 0.050 |
Why?
|
| Blood Transfusion, Autologous | 1 | 2023 | 9 | 0.050 |
Why?
|
| Prothrombin | 1 | 2023 | 15 | 0.050 |
Why?
|
| Animals | 2 | 2016 | 10415 | 0.050 |
Why?
|
| Pyridones | 1 | 2023 | 35 | 0.050 |
Why?
|
| Factor VIII | 1 | 2023 | 19 | 0.050 |
Why?
|
| Biopsy | 1 | 2024 | 206 | 0.050 |
Why?
|
| Rivaroxaban | 1 | 2023 | 29 | 0.050 |
Why?
|
| Sex | 1 | 2023 | 5 | 0.050 |
Why?
|
| Factor VIIa | 1 | 2023 | 29 | 0.050 |
Why?
|
| Factor Xa Inhibitors | 1 | 2023 | 54 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 12 | 0.050 |
Why?
|
| Aftercare | 1 | 2022 | 33 | 0.050 |
Why?
|
| Apolipoproteins E | 1 | 2002 | 44 | 0.050 |
Why?
|
| Hemoglobins | 1 | 2022 | 118 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2022 | 35 | 0.050 |
Why?
|
| Current Procedural Terminology | 1 | 2021 | 11 | 0.050 |
Why?
|
| Time Factors | 2 | 2019 | 1591 | 0.050 |
Why?
|
| Phylogeny | 1 | 2024 | 479 | 0.050 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 165 | 0.050 |
Why?
|
| Lipoproteins | 1 | 2002 | 99 | 0.050 |
Why?
|
| Academic Medical Centers | 1 | 2021 | 75 | 0.050 |
Why?
|
| Faculty, Medical | 1 | 2021 | 54 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2022 | 478 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2021 | 104 | 0.040 |
Why?
|
| Meningitis | 1 | 2020 | 11 | 0.040 |
Why?
|
| Early Detection of Cancer | 1 | 2022 | 126 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2021 | 108 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 194 | 0.040 |
Why?
|
| Educational Measurement | 1 | 2021 | 127 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2022 | 220 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2021 | 143 | 0.040 |
Why?
|
| International Classification of Diseases | 1 | 2020 | 36 | 0.040 |
Why?
|
| Prognosis | 1 | 2022 | 802 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2021 | 253 | 0.040 |
Why?
|
| Sepsis | 1 | 2020 | 84 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2021 | 433 | 0.040 |
Why?
|
| Pregnancy | 1 | 2024 | 1191 | 0.040 |
Why?
|
| Treatment Failure | 1 | 2019 | 69 | 0.040 |
Why?
|
| Liver | 1 | 2022 | 440 | 0.040 |
Why?
|
| Comorbidity | 1 | 2020 | 258 | 0.040 |
Why?
|
| Curriculum | 1 | 2021 | 291 | 0.040 |
Why?
|
| Hypotension | 1 | 2019 | 19 | 0.040 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2019 | 42 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 288 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 1248 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2020 | 399 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2019 | 474 | 0.040 |
Why?
|
| Analgesia | 1 | 1998 | 13 | 0.040 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 243 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2002 | 366 | 0.040 |
Why?
|
| Incidence | 1 | 2019 | 562 | 0.040 |
Why?
|
| Hospitalization | 1 | 2019 | 198 | 0.040 |
Why?
|
| Models, Psychological | 1 | 1998 | 81 | 0.040 |
Why?
|
| Pain Measurement | 1 | 1998 | 166 | 0.030 |
Why?
|
| Chronic Disease | 1 | 1998 | 271 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2019 | 887 | 0.030 |
Why?
|
| Alberta | 1 | 2011 | 3 | 0.020 |
Why?
|
| Learning Curve | 1 | 2011 | 13 | 0.020 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 37 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 2002 | 8 | 0.010 |
Why?
|
| Genetics, Population | 1 | 2002 | 73 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2002 | 185 | 0.010 |
Why?
|
| Alleles | 1 | 2002 | 350 | 0.010 |
Why?
|
| Genotype | 1 | 2002 | 456 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2002 | 242 | 0.010 |
Why?
|
| Cholesterol | 1 | 2002 | 201 | 0.010 |
Why?
|
| Phenotype | 1 | 2002 | 680 | 0.010 |
Why?
|